Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 4/20 | 0.32 |
| ▸ | EDNRA | P25101 | 2/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13382350 | 0.95 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL262408 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1HDAC4KMT2A | |
| SCHEMBL1461298 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1HDAC4KMT2A | |
| SCHEMBL262619 | 0.93 | L3MBTL1 (0.40) | KDM4EATML3MBTL1HDAC4KMT2A | |
| SCHEMBL12461093 | 0.93 | KDM4E (0.37) | KDM4EATML3MBTL1HDAC4KMT2A | |
| SCHEMBL262725 | 0.93 | KDM4E (0.37) | KDM4EATML3MBTL1HDAC4KMT2A | |
| SCHEMBL13433176 | 0.93 | KDM4E (0.37) | KDM4EATML3MBTL1HDAC4KMT2A | |
| SCHEMBL13669396 | 0.93 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4PDK2 | |
| SCHEMBL13669175 | 0.93 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4PDK2 | |
| SCHEMBL13428285 | 0.93 | KDM4E (0.34) | KDM4EATML3MBTL1HDAC4PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9650519-B2 | Ink composition, organic electroluminescence element, and electronic apparatus | SONY CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9650519-B2 | Ink composition, organic electroluminescence element, and electronic apparatus | SONY CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-20170073528-A1 | INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC APPARATUS | MAGNOLIA BLUE CORPORATION (JP) | 2017-03-16 | — | — | US | disclosed |
| US-20170073528-A1 | INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC APPARATUS | MAGNOLIA BLUE CORPORATION (JP) | 2017-03-16 | — | — | US | disclosed |
| US-8183793-B2 | Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-22 | — | — | US | disclosed |
| US-8183793-B2 | Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-22 | — | — | US | disclosed |
| US-20110050118-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-03 | — | — | US | disclosed |
| US-20110050118-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-03 | — | — | US | disclosed |
| US-20080107918-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-05-08 | — | — | US | disclosed |
| WO-2008026614-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110050118-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | ALAD, CYP2C9, CYP1A1 | KDM4E 2175/4885ATM 527/4885L3MBTL1 3456/4885 |
| US-20080107918-A1 | METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE | ALAD, CYP2C9, CYP1A1 | KDM4E 2175/4885ATM 527/4885L3MBTL1 3456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.